Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × cabozantinib × 30 days × Clear all

Phase

Status

Recruiting 16 Active not recruiting 12 Terminated 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Neurofibroma, Plexiform 1

Interventions

Specimen Handling 34 Magnetic Resonance Spectroscopy 21 Biopsy 19 Cyclophosphamide 18 pembrolizumab 14 Paclitaxel 14 Gemcitabine 13 Carboplatin 13 Azacitidine 13 venetoclax 12 fludarabine 11 Drug Therapy 11 Docetaxel 11 Standard of Care 10 Radiotherapy 10 Oxaliplatin 10 Nivolumab 10 Cytarabine 10 Cisplatin 10 Bevacizumab 10 Fluorouracil 9 Injections 8 Dexamethasone 8 Capecitabine 7 blinatumomab 6 X-Rays 6 Surgical Procedures, Operative 6 Radiosurgery 6 Leucovorin 6 Interviews as Topic 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06502171 2026-03-12

NF113

University of Alabama at Birmingham

Phase 1 Not yet recruiting

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡